The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R/S)-N-methyl-1-(4,5,6,8-tetrahydrothieno[2,3-c]oxepin-8-yl)methanamine ID: ALA5076544
PubChem CID: 166625859
Max Phase: Preclinical
Molecular Formula: C10H15NOS
Molecular Weight: 197.30
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CNCC1OCCCc2ccsc21
Standard InChI: InChI=1S/C10H15NOS/c1-11-7-9-10-8(4-6-13-10)3-2-5-12-9/h4,6,9,11H,2-3,5,7H2,1H3
Standard InChI Key: QSVFBEFJPQNHHR-UHFFFAOYSA-N
Molfile:
RDKit 2D
13 14 0 0 0 0 0 0 0 0999 V2000
35.3347 -23.8533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8161 -23.1832 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3274 -22.5185 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
33.1429 -22.4822 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.8178 -23.2348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.1927 -23.9146 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9192 -22.2870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5423 -22.7760 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5487 -23.6027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9561 -24.0802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0914 -21.4765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4758 -20.9220 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.6877 -21.1780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 1 1 0
1 2 2 0
2 3 1 0
3 8 1 0
4 5 1 0
5 6 1 0
4 7 1 0
8 9 2 0
9 10 1 0
10 6 1 0
7 8 1 0
7 11 1 0
11 12 1 0
12 13 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 197.30Molecular Weight (Monoisotopic): 197.0874AlogP: 1.97#Rotatable Bonds: 2Polar Surface Area: 21.26Molecular Species: BASEHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 9.26CX LogP: 1.94CX LogD: 0.09Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.78Np Likeness Score: -0.68
References 1. Heffernan MLR, Herman LW, Brown S, Jones PG, Shao L, Hewitt MC, Campbell JE, Dedic N, Hopkins SC, Koblan KS, Xie L.. (2022) Ulotaront: A TAAR1 Agonist for the Treatment of Schizophrenia., 13 (1.0): [PMID:35047111 ] [10.1021/acsmedchemlett.1c00527 ]